Theravance Biopharma Ownership | Who Owns Theravance Biopharma?
Theravance Biopharma Ownership Summary
Theravance Biopharma is owned by 94.15% institutional investors, 4.68% insiders, and 1.17% retail investors. Madison avenue partners, lp is the largest institutional shareholder, holding 17.96% of TBPH shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.50% of its assets in Theravance Biopharma shares.
TBPH Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Theravance Biopharma | 94.15% | 4.68% | 1.17% |
| Sector | Healthcare Stocks | 50.62% | 12.41% | 36.97% |
| Industry | Biotech Stocks | 49.15% | 12.15% | 38.70% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Madison avenue partners, lp | 9.21M | 17.96% | $156.61M |
| Weiss asset management lp | 7.46M | 14.54% | $126.77M |
| Blackrock funding, inc. /de | 4.56M | 8.90% | $77.56M |
| Blackrock | 3.78M | 7.83% | $32.06M |
| Newtyn management | 3.43M | 6.70% | $58.38M |
| Irenic capital management lp | 2.76M | 5.38% | $46.94M |
| Vanguard group | 2.37M | 4.69% | $44.29M |
| Vanguard capital management | 1.77M | 3.45% | $30.12M |
| State street | 1.33M | 2.59% | $22.59M |
| Two sigma investments, lp | 1.23M | 2.39% | $20.83M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Newtyn management | 3.43M | 7.29% | $58.38M |
| Madison avenue partners, lp | 9.21M | 6.74% | $156.61M |
| Irenic capital management lp | 2.76M | 2.25% | $46.94M |
| Rangeley capital | 99.50K | 1.55% | $1.69M |
| Weiss asset management lp | 7.46M | 1.33% | $126.77M |
| Oasis management | 583.49K | 0.53% | $9.92M |
| Cannon global investment management | 10.32K | 0.50% | $175.46K |
| Jackson creek investment advisors | 85.51K | 0.48% | $1.44M |
| Camber capital management lp | 450.00K | 0.47% | $4.96M |
| Nverses capital | 14.77K | 0.39% | $251.12K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Mackenzie financial | 985.85K | 0.02% | 737.17K |
| Citadel advisors | 506.67K | 0.00% | 420.58K |
| Sixth street partners management company | 321.15K | 0.00% | 321.15K |
| Glazer capital | 301.83K | 0.13% | 301.83K |
| Blackrock funding, inc. /de | 4.56M | 0.00% | 266.20K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Baupost group llc/ma | - | - | -4.20M |
| Newtyn management | 3.43M | 7.29% | -1.41M |
| Pictet asset management sa | - | - | -684.89K |
| Camber capital management lp | 450.00K | 0.47% | -550.00K |
| Blackrock | 3.78M | 0.00% | -428.18K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Sixth street partners management company | 321.15K | 0.00% | 321.15K | $5.46M |
| Glazer capital | 301.83K | 0.13% | 301.83K | $5.13M |
| Algert global | 199.71K | 0.05% | 199.71K | $2.92M |
| Caption management | 163.70K | 0.02% | 163.70K | $2.66M |
| Wedge capital management l l p/nc | 128.84K | 0.04% | 128.84K | $2.19M |
Sold Out
| Holder | Change |
|---|---|
| Sbi securities | -2.00 |
| True wealth design | -2.00 |
| Capital performance advisors llp | -5.00 |
| Wealthspire advisors | -12.00 |
| Nelson, van denburg & campbell wealth management group | -13.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 182 | 1.68% | 48,280,263 | -3.63% | 94 | 0.99% | 100 | - | 52 | 10.64% |
| Mar 31, 2026 | 172 | 0.58% | 46,814,907 | -5.60% | 93 | 0.97% | 97 | -2.02% | 45 | -4.26% |
| Dec 31, 2025 | 88 | -47.31% | 16,063,224 | -66.80% | 31 | 0.34% | 45 | -47.67% | 29 | -27.50% |
| Sep 30, 2025 | 70 | -48.53% | 10,629,292 | -77.11% | 21 | 0.24% | 37 | -52.56% | 14 | -56.25% |
| Jun 30, 2025 | 135 | 2.27% | 46,426,014 | 3.43% | 93 | 1.15% | 77 | 32.76% | 32 | -31.91% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 1.30M | 2.50% | -29.00K |
| Vanguard Morn Total Stk Mkt Idx Investor | 1.30M | 2.50% | -29.00K |
| Vanguard MStar Total Stk Mkt Idx Invest | 1.30M | 2.50% | - |
| Vanguard US Total Market Shares ETF | 1.07M | 2.15% | - |
| iShares Russell 2000 ETF | 1.03M | 1.98% | -18.24K |
| Pictet Biopharmaceutical Mother | 652.30K | 1.32% | -349.81K |
| Vanguard Institutional Extnd Mkt Idx Tr | 436.47K | 0.84% | 818.00 |
| Fidelity Small Cap Index | 381.00K | 0.74% | 853.00 |
| Invesco Biotechnology & Genome ETF | 366.33K | 0.71% | - |
| iShares Biotechnology ETF | 350.75K | 0.68% | -1.07K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jul 01, 2026 | Samaha Eli | - | Sell | $642.63K |
| Jun 29, 2026 | Samaha Eli | - | Sell | $4.72M |
| Jun 30, 2026 | Samaha Eli | - | Sell | $428.79K |
| Jun 15, 2026 | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Sell | $54.53K |
| Jun 15, 2026 | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Sell | $54.56K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | 3 |
| 2026 Q1 | - | 3 |
| 2025 Q4 | - | 11 |
| 2025 Q3 | - | 3 |
| 2025 Q2 | - | 2 |
TBPH Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools